Trial Identifier: | D5180R00028 |
Sponsor: | AstraZeneca |
Start Date: | June 2024 |
Primary Completion Date: | November 2024 |
Study Completion Date: | November 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.